Exercise training and inspiratory muscle training in patients with bronchiectasis
http://www.100md.com
《胸》
Correspondence to:
Dr R S Goldstein
Professor of Medicine and Physical Therapy, University of Toronto, West Park Healthcare Centre, 82 Buttonwood Avenue, Toronto, Ontario, M6M 2J5 Canada; rgoldstein@westpark.org
Evidence for effectiveness of pulmonary rehabilitation in patients with bronchiectasis
Keywords: exercise training; bronchiectasis; inspiratory muscle training; pulmonary rehabilitation
Pulmonary rehabilitation is now recommended by many professional respiratory societies as the standard of care for patients with chronic lung disease.1–3 This has occurred because well designed prospective randomised controlled trials using valid responsive and interpretable outcome measures have convinced clinicians of its effectiveness. Benefits of pulmonary rehabilitation include improved health related quality of life, increased functional exercise capacity, and reduced healthcare resource utilisation.4–6 The key determinant of the success of rehabilitation, and the one best supported by clinical evidence, is exercise training.
A frequently encountered challenge in respiratory medicine is that of extending the clinical application of treatment modalities, for which evidence was derived from one clinical circumstance, to other circumstances or diagnostic categories. For example, we recognise that long term oxygen therapy is life extending for patients with stable severe chronic obstructive pulmonary disease (COPD) who have resting hypoxaemia, but still wrestle with the challenge of whether it should be provided for those with transient exercise or sleep hypoxaemia, or those with other diagnoses not involved in landmark multicentre clinical trials. Such decisions are made using a combination of scientific evidence and clinical judgement, the latter being a less well defined entity that includes knowledge, experience, and common sense.
The paper by Newall and colleagues7 in this issue of Thorax obliges us to consider the evidence in favour of extending pulmonary rehabilitation to patients with bronchiectasis, a chronic suppurative lung disease often characterised by airflow obstruction and hyperinflation and associated with decreased health related quality of life and reduced functional exercise capacity. Two issues arise: (1) does a prescribed regimen of physical training produce improvements in physiological or clinical outcomes compared with no physical training, and (2) should such a programme include inspiratory muscle training (IMT)?
There are marked similarities in the disease manifestations of COPD and bronchiectasis, both having a primary pulmonary impairment and both having secondary peripheral muscle, nutritional and psychological impairments. Given the similarities in clinical outcomes of reduced ability and participation, it is not too far of a stretch to conclude that both conditions might benefit from an exercise rehabilitation programme.
In 1990 Foster and colleagues8 published a report on pulmonary rehabilitation in lung diseases other than COPD in which seven patients with bronchiectasis were included in the 32 patients enrolled in an inpatient programme. The 6 minute walk distance in patients with bronchiectasis improved by approximately 72 metres, a distance comparable to that achieved by patients with COPD. Despite the small number of patients studied, the authors concluded that patients with diagnoses other than COPD can and do benefit from an inpatient multidisciplinary rehabilitation programme. In 2002 Bradley and colleagues9 undertook a systematic review of physical training for bronchiectasis in which they wished to determine whether exercise training improved or prevented deterioration in physiological and clinical outcomes compared with no exercise. They identified three studies, one of which did not meet the inclusion criteria and two of which were in abstract form (both by the current author). Bradley concluded that there was a need for well designed, adequately powered, randomised controlled clinical trials to assess the net benefit of adherence to different forms of prescribed physical training in patients with bronchiectasis.
The study by Newall et al is therefore welcomed as one of only a few published trials in this area. They randomised 32 patients with idiopathic bronchiectasis into one of three groups: pulmonary rehabilitation plus inspiratory muscle training (PR-IMT), pulmonary rehabilitation plus sham IMT (PR-SHAM), and a control group. The rehabilitation patients all underwent 8 weeks of exercise training, attending for supervised outpatient sessions twice a week with a third session at home. Patients exercised for 45 minutes at 80% peak heart rate using a combination of cycle, treadmill, and stair climbing exercises.
The 23 patients randomised to exercise rehabilitation improved their constant power exercise endurance, measured using a treadmill, as well as their incremental shuttle walk test. No differences in peak oxygen uptake occurred, but there were significant increases in endurance exercise capacity, the magnitude of which was similar in the groups whose regimen included IMT and sham IMT. It would therefore appear that the first question has been answered, albeit in a small pilot sized trial—namely, that exercise training improves exercise capacity in patients with bronchiectasis.
The second question may be slightly more problematic depending on one’s view of the merits of IMT, about which a great deal has been written since it was first seriously considered as a clinical modality in the 1980s. Although it has been suggested that IMT may be an important adjunct to pulmonary rehabilitation, many clinicians have refrained from including it in their rehabilitation programme as clinical trials and meta-analyses still differ on whether a modest improvement in inspiratory muscle pressure can be translated into meaningful clinical improvements.10–13 Respiratory muscles are autotrained against the increased respiratory obstructive and elastic loads associated with airflow limitation and hyperinflation, respectively. It has been shown that training using alinear resistors, pressure threshold loads, or isocapnic hyperpnoea will improve test function, but it is necessary for such training to extend the impact on clinical outcomes beyond exercise alone for it to be routinely included.14 There is evidence that IMT improves inspiratory muscle strength, dyspnoea, and exercise tolerance,15 but these effects are more likely to be obvious in patients with markedly reducted inspiratory muscle strength.
In the study by Newall et al, both the PR-IMT and the PR-SHAM groups had small but similar improvements in respiratory muscle strength. The addition of IMT did not add to outcomes beyond this increase. It could be argued that small sample size and only a modest baseline reduction of inspiratory muscle strength prevented a more conclusive answer but, as with COPD, many clinicians will regard these data as insufficient to warrant using IMT for patients with bronchiectasis. Indeed, a recent meta-analysis of IMT for patients with COPD by Geddes and colleagues16 concluded that it was only effective when using targeted devices that control or provide a target for training intensity.
There are several unanswered issues regarding training for patients with bronchiectasis which mirror the challenges of training for patients with COPD. The intensity, frequency, and duration of training, as well as the optimal strategy for maintenance of benefit, are common to both conditions. Additional issues specific to rehabilitation of patients with bronchiectasis include the optimal approaches for secretion clearance and specific education self-management action plans. Such issues should attract further well designed trials among this population. Bronchiectasis is no longer as common a condition as it used to be, but it is still present and many clinicians will continue to enrol patients with bronchiectasis in pulmonary rehabilitation, modifying the programme to help them tackle the issues specific to their condition. We will also continue to do so, but with slightly more comfort following the evidence of effectiveness described by Newall and colleagues.
REFERENCES
O’Donnell DE, Aaron S, Bourbeau J, et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004;11 (Suppl B) :7B–59B.
COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52 (Suppl 5).
European Respiratory Society. Consensus statement: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398–420.
Lacasse Y , Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115–9.
Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362–8.
Bourbeau J , Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585–91.
Newall C , Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943–8.
Foster S , Thomas HM. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:601–4.
Bradley J , Moran F, Greenstone M. Physical training for bronchiectasis (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
Smith K , Cook D, Guyatt GH, et al. Respiratory muscle training, chronic airflow limitation: a meta analysis. Am Rev Respir Dis 1992;145:533–9.
Lotters F , Van Tol B, Kwakkel G, et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta analysis. Eur Respir J 2002;20:570–6.
Lacasse Y , Guyatt GH, Goldstein RS. The components of respiratory rehabilitation programme. A systematic overview. Chest 1997;111:1077–88.
Weiner P , Magadle R, Beckham W, et al. Maintenance of inspiratory muscle training in COPD patients: 1 year follow-up. Eur Respir J 2004;23:61–5.
Polkey MI, Moxham J. Improvement in volitional tests of muscle function alone might not be adequate evidence that inspiratory muscle training is effective. Eur Respir J 2004;23:5–6.
Harver A , Mahler DA, Daubenspck JA. Target inspiratory muscle training improve respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989;111:1171.
Geddes EL, Reid WD, Crowe J, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med 2005; (in press).(R S Goldstein)
Dr R S Goldstein
Professor of Medicine and Physical Therapy, University of Toronto, West Park Healthcare Centre, 82 Buttonwood Avenue, Toronto, Ontario, M6M 2J5 Canada; rgoldstein@westpark.org
Evidence for effectiveness of pulmonary rehabilitation in patients with bronchiectasis
Keywords: exercise training; bronchiectasis; inspiratory muscle training; pulmonary rehabilitation
Pulmonary rehabilitation is now recommended by many professional respiratory societies as the standard of care for patients with chronic lung disease.1–3 This has occurred because well designed prospective randomised controlled trials using valid responsive and interpretable outcome measures have convinced clinicians of its effectiveness. Benefits of pulmonary rehabilitation include improved health related quality of life, increased functional exercise capacity, and reduced healthcare resource utilisation.4–6 The key determinant of the success of rehabilitation, and the one best supported by clinical evidence, is exercise training.
A frequently encountered challenge in respiratory medicine is that of extending the clinical application of treatment modalities, for which evidence was derived from one clinical circumstance, to other circumstances or diagnostic categories. For example, we recognise that long term oxygen therapy is life extending for patients with stable severe chronic obstructive pulmonary disease (COPD) who have resting hypoxaemia, but still wrestle with the challenge of whether it should be provided for those with transient exercise or sleep hypoxaemia, or those with other diagnoses not involved in landmark multicentre clinical trials. Such decisions are made using a combination of scientific evidence and clinical judgement, the latter being a less well defined entity that includes knowledge, experience, and common sense.
The paper by Newall and colleagues7 in this issue of Thorax obliges us to consider the evidence in favour of extending pulmonary rehabilitation to patients with bronchiectasis, a chronic suppurative lung disease often characterised by airflow obstruction and hyperinflation and associated with decreased health related quality of life and reduced functional exercise capacity. Two issues arise: (1) does a prescribed regimen of physical training produce improvements in physiological or clinical outcomes compared with no physical training, and (2) should such a programme include inspiratory muscle training (IMT)?
There are marked similarities in the disease manifestations of COPD and bronchiectasis, both having a primary pulmonary impairment and both having secondary peripheral muscle, nutritional and psychological impairments. Given the similarities in clinical outcomes of reduced ability and participation, it is not too far of a stretch to conclude that both conditions might benefit from an exercise rehabilitation programme.
In 1990 Foster and colleagues8 published a report on pulmonary rehabilitation in lung diseases other than COPD in which seven patients with bronchiectasis were included in the 32 patients enrolled in an inpatient programme. The 6 minute walk distance in patients with bronchiectasis improved by approximately 72 metres, a distance comparable to that achieved by patients with COPD. Despite the small number of patients studied, the authors concluded that patients with diagnoses other than COPD can and do benefit from an inpatient multidisciplinary rehabilitation programme. In 2002 Bradley and colleagues9 undertook a systematic review of physical training for bronchiectasis in which they wished to determine whether exercise training improved or prevented deterioration in physiological and clinical outcomes compared with no exercise. They identified three studies, one of which did not meet the inclusion criteria and two of which were in abstract form (both by the current author). Bradley concluded that there was a need for well designed, adequately powered, randomised controlled clinical trials to assess the net benefit of adherence to different forms of prescribed physical training in patients with bronchiectasis.
The study by Newall et al is therefore welcomed as one of only a few published trials in this area. They randomised 32 patients with idiopathic bronchiectasis into one of three groups: pulmonary rehabilitation plus inspiratory muscle training (PR-IMT), pulmonary rehabilitation plus sham IMT (PR-SHAM), and a control group. The rehabilitation patients all underwent 8 weeks of exercise training, attending for supervised outpatient sessions twice a week with a third session at home. Patients exercised for 45 minutes at 80% peak heart rate using a combination of cycle, treadmill, and stair climbing exercises.
The 23 patients randomised to exercise rehabilitation improved their constant power exercise endurance, measured using a treadmill, as well as their incremental shuttle walk test. No differences in peak oxygen uptake occurred, but there were significant increases in endurance exercise capacity, the magnitude of which was similar in the groups whose regimen included IMT and sham IMT. It would therefore appear that the first question has been answered, albeit in a small pilot sized trial—namely, that exercise training improves exercise capacity in patients with bronchiectasis.
The second question may be slightly more problematic depending on one’s view of the merits of IMT, about which a great deal has been written since it was first seriously considered as a clinical modality in the 1980s. Although it has been suggested that IMT may be an important adjunct to pulmonary rehabilitation, many clinicians have refrained from including it in their rehabilitation programme as clinical trials and meta-analyses still differ on whether a modest improvement in inspiratory muscle pressure can be translated into meaningful clinical improvements.10–13 Respiratory muscles are autotrained against the increased respiratory obstructive and elastic loads associated with airflow limitation and hyperinflation, respectively. It has been shown that training using alinear resistors, pressure threshold loads, or isocapnic hyperpnoea will improve test function, but it is necessary for such training to extend the impact on clinical outcomes beyond exercise alone for it to be routinely included.14 There is evidence that IMT improves inspiratory muscle strength, dyspnoea, and exercise tolerance,15 but these effects are more likely to be obvious in patients with markedly reducted inspiratory muscle strength.
In the study by Newall et al, both the PR-IMT and the PR-SHAM groups had small but similar improvements in respiratory muscle strength. The addition of IMT did not add to outcomes beyond this increase. It could be argued that small sample size and only a modest baseline reduction of inspiratory muscle strength prevented a more conclusive answer but, as with COPD, many clinicians will regard these data as insufficient to warrant using IMT for patients with bronchiectasis. Indeed, a recent meta-analysis of IMT for patients with COPD by Geddes and colleagues16 concluded that it was only effective when using targeted devices that control or provide a target for training intensity.
There are several unanswered issues regarding training for patients with bronchiectasis which mirror the challenges of training for patients with COPD. The intensity, frequency, and duration of training, as well as the optimal strategy for maintenance of benefit, are common to both conditions. Additional issues specific to rehabilitation of patients with bronchiectasis include the optimal approaches for secretion clearance and specific education self-management action plans. Such issues should attract further well designed trials among this population. Bronchiectasis is no longer as common a condition as it used to be, but it is still present and many clinicians will continue to enrol patients with bronchiectasis in pulmonary rehabilitation, modifying the programme to help them tackle the issues specific to their condition. We will also continue to do so, but with slightly more comfort following the evidence of effectiveness described by Newall and colleagues.
REFERENCES
O’Donnell DE, Aaron S, Bourbeau J, et al. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J 2004;11 (Suppl B) :7B–59B.
COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52 (Suppl 5).
European Respiratory Society. Consensus statement: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398–420.
Lacasse Y , Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115–9.
Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362–8.
Bourbeau J , Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585–91.
Newall C , Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943–8.
Foster S , Thomas HM. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:601–4.
Bradley J , Moran F, Greenstone M. Physical training for bronchiectasis (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2003.
Smith K , Cook D, Guyatt GH, et al. Respiratory muscle training, chronic airflow limitation: a meta analysis. Am Rev Respir Dis 1992;145:533–9.
Lotters F , Van Tol B, Kwakkel G, et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta analysis. Eur Respir J 2002;20:570–6.
Lacasse Y , Guyatt GH, Goldstein RS. The components of respiratory rehabilitation programme. A systematic overview. Chest 1997;111:1077–88.
Weiner P , Magadle R, Beckham W, et al. Maintenance of inspiratory muscle training in COPD patients: 1 year follow-up. Eur Respir J 2004;23:61–5.
Polkey MI, Moxham J. Improvement in volitional tests of muscle function alone might not be adequate evidence that inspiratory muscle training is effective. Eur Respir J 2004;23:5–6.
Harver A , Mahler DA, Daubenspck JA. Target inspiratory muscle training improve respiratory muscle function and reduces dyspnea in patients with chronic obstructive pulmonary disease. Ann Intern Med 1989;111:1171.
Geddes EL, Reid WD, Crowe J, et al. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: a systematic review. Respir Med 2005; (in press).(R S Goldstein)